SGX queries Biolidics on timing of disclosure that authorities had approved its Covid-19 test kits
Medical technology firm says it made disclosure after it was certain kits could be commercialised
Singapore
BIOLIDICS Ltd believes that it only became material to disclose that the firm had received approval for its virus test kits from Singapore's Health Sciences Authority (HSA) after it was certain that the kits could be commercialised.
In an exchange filing on Thursday, the firm also said it only received approval for the product to be manufactured and marketed under its own brand some time later.
TRENDING NOW
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
Tiger Beer lines up new products as Singapore operations’ role shifts from brewing to innovation
Single founders, billion-dollar valuations: AI is minting unicorn startups at birth